Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports
At least 20 people in Japan who took Amgen's rare disease drug have died, while 22 others developed potentially fatal liver injuries, the Wall Street Journal reported on Friday, citing partner Kissei Pharmaceutical.
Open original source